Quakertown, PA, United States of America

Benjamin Roadarmel

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Benjamin Roadarmel

Introduction

Benjamin Roadarmel is a notable inventor based in Quakertown, PA (US). He has made significant contributions to the field of polymeric delivery systems, which are crucial for the effective delivery of biologics to cells. His work has implications for various applications in medicine and biotechnology.

Latest Patents

Benjamin Roadarmel holds a patent for a polymeric delivery system that delivers biologics to cells. This innovative system includes polyplexes, where each polyplex consists of at least one charged polymer and at least one biologic. The charged polymer is a polyester copolymer of a polyol and a polycarboxylic acid, modified with a charged moiety that has an opposite charge from the biologic. Additionally, the polymeric delivery system can include self-assembled particles that consist of a block copolymer and a biologic associated with it. This patent showcases his expertise in creating advanced delivery mechanisms for therapeutic agents.

Career Highlights

Benjamin Roadarmel is currently employed at The Secant Group, LLC, where he continues to develop innovative solutions in the field of polymer science. His work at this company has allowed him to collaborate with other talented professionals and contribute to cutting-edge research and development.

Collaborations

Some of Benjamin's coworkers include Jeremy J Harris and Scott Radzinski. Their collaboration fosters a creative environment that enhances the development of new technologies and solutions in their field.

Conclusion

Benjamin Roadarmel's contributions to polymeric delivery systems highlight his innovative spirit and dedication to advancing medical technology. His patent reflects a significant step forward in the effective delivery of biologics, showcasing the potential for improved therapeutic outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…